纳米/微尺度向RNA输送系统用于癌症治疗
Xiaobin Li1, Junyu Liu1, Yun Chen1
1Institute of Biopharmaceutical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
International journal of pharmaceutics
|December 5, 2025
概括
RNA疗法提供了一个有前途的癌症治疗方法,但面临着交付挑战. 本综述探讨了纳米/微尺度的传递系统,以克服生物障碍并提高治疗疗效,以改善癌症治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- RNA疗法是一种革命性的癌症治疗方式.
- 临床转化受到生物障碍的阻碍,如酶降解,RES清除和不良转染.
- 纳米/微尺度交付系统对于克服这些局限性至关重要.
研究的目的:
- 为癌症治疗提供纳米/微尺度向RNA输送系统的全面审查.
- 批判性地分析与这些交付系统相关的挑战和机会.
- 讨论临床瘤学中RNA输送的未来前景.
主要方法:
- 关于各种纳米/微尺度矢量和技术的文献综述.
- 分析不同的输送平台,包括脂质纳米颗粒,聚合物微粒,水凝,微针,外体,纳米颗粒,MOF,COF和活细胞.
- 讨论有效的RNA输送的挑战和潜在解决方案.
主要成果:
- 识别了各种纳米/微尺度系统,用于向癌症中的RNA输送.
- 突出了实现高疗效和最小化副作用的关键挑战.
- 强调了这些系统改善癌症治疗的潜力.
结论:
- 纳米/微尺度的向传递系统对于推进RNA癌症治疗至关重要.
- 克服生物障碍对于成功的临床应用至关重要.
- 通过基于RNA的策略,进一步的研究和开发对改善癌症治疗结果具有重大前景.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K


